Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Flamen, Patrick*" or (type exact bookEditor and editor="Flamen, Patrick*")

Add to list
- Conference Paper
- C3
Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters, Lionel D'Hondt, et al.

(2019) CANCER RESEARCH. 79(13, suppl.).
Add to list
- Conference Paper
- C3
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study

Alain Hendlisz, Rafael Caparica, Amelie Deleporte, Jean-Luc Van Laethem, Philippe Vergauwe, Marc Van den Eynde, Guido Deboever, Jozef Janssens, Gauthier Demolin, Stephane Holbrechts, et al.

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(15, suppl.).
Add to list
- Journal Article
- A1
- open access
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, Camille Van Bogaert, Jonathan Krygier, Thomas Guiot, Amelie Deleporte, Thierry Delaunoit, Karen Geboes (UGent) , Jean-Luc Van Laethem, et al.

(2019) BMC CANCER. 19.
Add to list
- Journal Article
- A2
- open access
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

Caroline Vandeputte, Pashalina Kehagias, Hakim El Housni, Lieveke Ameye, Jean-François Laes, Christine Desmedt, Christos Sotiriou, Amélie Deleporte, Francesco Puleo, Karen Geboes (UGent) , et al.

(2018) ONCOTARGET. 9(25). p.17756-17769
Add to list
- Conference Paper
- C3
Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Jean-Francois Laes, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters (UGent) , et al.

(2018) CANCER RESEARCH. In Cancer Research 78(13).
Add to list
- Conference Paper
- C3
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Hakim El Housni, Amelie Deleporte, Karen Geboes (UGent) , Thierry Delaunoit, Marc Peeters (UGent) , Gauthier Demolin, Lionel D'Hondt, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 36(15).
Add to list
- Journal Article
- A1
- open access
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Gwennaëlle Marin, Bruno Vanderlinden, Ioannis Karfis, Thomas Guiot, Zena Wimana, Patrick Flamen and Stefaan Vandenberghe (UGent)

(2017) EJNMMI PHYSICS. 4(1).
Add to list
- Conference Paper
- C3
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)

Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Tarek Kamoun, Thomas Guiot, Lieveke Ameye, Karen Geboes (UGent) , Thierry Delaunoit, Gauthier Demolin, Marc Peeters (UGent) , et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 35(Supplement 15).
Add to list
Pretreatment dosimetry in HCC radioembolization with 90Y glass microspheres cannot be invalidated with a bare visual evaluation of 99mTc-MAA uptake of colorectal metastases treated with resin microspheres

Carlo Chiesa, Bieke Lambert (UGent) , Marco Maccauro, Samer Ezziddin, Hojjat Ahmadzadehfar, Arnaud Dieudonné, Marta Cremonesi, Mark Konijnenberg, Michael Lassmann, Cinzia Pettinato, et al.

(2014) JOURNAL OF NUCLEAR MEDICINE. 55(7). p.1215-1216
Add to list
- Conference Paper
- C3
Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Alain Hendliz, Amélie Deleporte, Thierry Delaunois, Marc Peeters (UGent) , Gauthier Demolin, Jos Janssens, Stephane Holbrechts, Raphaël Maréchal, Javier Carasco, Marc Van Den Eynde, et al.

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(15, suppl.).

Academic Bibliography

Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer

Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer : a post hoc analysis of two non-randomized phase II trials

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor

Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer

High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy

Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)

Pretreatment dosimetry in HCC radioembolization with 90Y glass microspheres cannot be invalidated with a bare visual evaluation of 99mTc-MAA uptake of colorectal metastases treated with resin microspheres

Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study

Contents

Support

Contact